| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5c686089767d292b22d8968d15f29db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-18022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14143 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2000-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I266802-B |
| titleOfInvention |
G01n 33/569 200601 a i htw |
| abstract |
The present invention relates to the isolation and characterization of four major proteins derived from white spot syndrom virus (WSSV) having an estimated size of 28 kDa (VP28), 26 kDa (VP26), 24 kDa (VP24) and 19 kDa (VP19) and their use in the manufacture of a vaccine to protect crustaceans against infections with WSSV. The invention further provides for nucleotide sequences encoding said proteins and their use in recombinant production of said proteins. In addition the invention provides for antibodies raised against said proteins, their use in passive vaccination and diagnostic kits comprising said nucleic acids or said antibodies. |
| priorityDate |
1999-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |